Evelyn Partners Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.65M Buy
7,228
+2,040
+39% +$2.07M 0.18% 68
2025
Q4
$5.58M Buy
5,188
+133
+3% +$127K 0.15% 76
2025
Q3
$3.86M Sell
5,055
-58
-1% -$43.2K 0.11% 81
2025
Q2
$3.99M Buy
5,113
+225
+5% +$175K 0.12% 78
2025
Q1
$4.04M Buy
4,888
+1,032
+27% +$859K 0.13% 79
2024
Q4
$2.98M Buy
+3,856
New +$3.19M 0.1% 88

Other funds holding LLY

Evelyn Partners Investment Management's LLY Position: Q1 2026 in Review

Evelyn Partners Investment Management increased its Eli Lilly (LLY) stake by 39% in Q1 2026, buying an estimated $2.07M and bringing the position to 7,228 shares worth $6.65M. The position accounts for 0.18% of the portfolio, ranked #68.

Evelyn Partners Investment Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Evelyn Partners Investment Management held 7,228 shares of Eli Lilly worth $6.65M as of Q1 2026.
  • Evelyn Partners Investment Management bought 2,040 Eli Lilly shares in Q1 2026, an estimated $2.07M.
  • Eli Lilly made up 0.18% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #68 holding.
  • Evelyn Partners Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.